Doctor David Samadi, His Life Success and Career

Dr David Samadi is a renowned urologist. He practices urology at Lenox Hill Hospital. The certified urologist trained in diagnosing urologic diseases including kidney and prostate cancer. He also specializes in invasive cancer treatment.

Early Life

Dr David Samadi grew up in a Jewish community. At the age of 15 years, he fled to Belgium in pursuit of an education. He later joined Roslyn High School in New York. After completing his high school studies, he was awarded a full scholarship and earned him a direct entry to Stony Brook University. Afterwards, Dr David Samadi attained a bachelor’s degree in biochemistry prior to joining Montefiore Medical Centre for a postgraduate degree in the field of urology.

Education

In 1996, Dr David Samadi enrolled at the Albert Einstein College of Medicine for a degree in proctology. He later joined Memorial Sloan Kettering Cancer Centre for training in robotic radical prostatectomy. In 2002, Dr David Samadi joined Henri Mondor Hospital Creteil for oncology.

Career

David Samadi’s first practised urology at Columbia Presbyterian Hospital. In 2007, he joined Mt. Sinai School of Medicine and he was accorded the title- vice president of the urology department. He also served as the chief of robotics in the same organization. David Samadi was listed as New York’s highest-paid doctor in 2012. And his salary amounted to $7.6 million.

In 2013, Samadi shifted his team to Lenox Hill Hospital thereby becoming the head of urology as well as chief robotic surgery. Hofstra North Shore School of Medicine appointed him as the professor of urology.

Experience

David Samadi has performed more than 6,000 robotic surgeries on patients with prostate cancer. He owns a reliable practice at the Columbia Presbyterian. As the director of laparoscopic surgery, he oversees all surgeries.

Leadership

As a board-certified urologist, Dr David Samadi specializes in men’s health. He provides targeted therapies to treat and improve men’s health. Moreover, David Samadi trains urologists. He also lectures the trainees on the utilization of the robotic surgical system. He believes that the advent of technology magnifies the application of surgeries by giving surgeons greater dexterity and visualization when performing surgeries.

Medical Author

Dr David Samadi is also a renowned author and lecturer. He uses his talent in medicine to disseminate information on urologic oncology, laparoscopic surgery and prostate cancer. He is the author of the Journal of the Society of Laparoscopic Surgeons and Journal of Robotic Surgery.

Awards and Recognition

Dr David Samadi is also fond of people. Due to this admirable attribute, he was accorded the award of most compassionate doctor award between 2010 and 2013. Furthermore, in 2012, he was named the community partner of the year.

To know more click: here.

Eric Lefkofsky Who is Also a Co-Founder of Groupon

Cancer has recently become a major illness facing almost 40% of the adults’ population in U.S. based on the statistics provided by the National Cancer institute (NCI), over 14.5m citizens in U.S have been diagnosed with cancer. The statistics reveal that this number is to project up to 19 million in the year 2024. The slow growth has been mainly attributed to better projections and advances in medical technology to fight cancer. Companies such as Tempus have played a significant in this progress. Tempus is currently leading the charge in data enabled precision medicine. It is co-founded by Eric Lefkofsky who is also a co-founder of Groupon.

Technological developments such as electronic health records (EHRs) has made medical practice to be perceived to speed up with modern technology. However, that’s not the case as it is with the perception of many individuals. Eric Lefkofsky had not realized how insufficient data collection and advancement in medical technology was until his wife was found with breast cancer. He realised that the main ordeal was not the generation of data. The major concern is how that generated data is used. This was the main reason that drove to the formation of Tempus. The main objective of the formation of the firm was to improve the way cancer care is provided. The firm also had a major concern of overcoming the ways in which important information is gathered and stored for cancer patients. They were able to transform the text fields with pertinent notes into a well-structured data which can be used in advanced treatment of cancer patients.

The significant works of Eric Lefkofsky and Tempus have allowed clinical information about a cancer patient to be combined with molecular information which has been gathered via genome sequence. This is of great importance since human genes contains information for a lot of things which aids in fighting diseases such as cancer. Individuals such as Eric Lefkofsky and other medical geniuses advocating for data enabled precision believe that through advanced technology such as Tempus, cancer patient can receive quality treatment.

Eric Lefkofsky was born in September 1969 in Michigan. The most interesting thing with him is that he is less than 50 years if age.

He is well educated since in 1991 he got his degree in the University of Michigan with high honours.

Eric Lefkofsky info: lefkofskyfoundation.com/

Seattle Genetics Receives Huge Contribution For Genetic Disease Research

Seattle Genetics has invented an intensive portfolio that has made tremendous strides in treatment for patients that have unmet medical needs. This is the pipeline for the treatment that they provide to their patients. They focus on serious and ultrarare diseases that aren’t researched like they should be. Each year thousands of their loyal investors are willing to contribute to research products with Seattle Genetics. They want to save lives across the world and make sure everyone is able to live a productive lifestyle one patient at a time. Their treatment methods are safe and reliable for chronic pain and genetic diseases.
Seattle Genetics (SGEN) Clay B. Siegall on Q2 2016 Results – Earnings Call Transcript
Seatlle Genetics is committed to creating novelty medical solutions that will cure thousands of individuals from genetic diseases. In fact, they are a biopharmaceutical company that provides top of the line treatment to millions of people each year that are suffering from chronic pain. You don’t have to suffer with pain on your own because may technological advances are happening everyday at Seattle Genetics to ensure that all of the world is able to live a healthy lifestyle. You won’t be disappointed with the way that many people are becoming stronger around the world.

One life at a time they are striving to build a stronger community at Seattle Genetics for the benefit of all mankind. Siegall admits that the unaddressed medical needs of many people are not being met and something has to be done about that. He is committed to the advancement of the community and many people suffering from disease to be able to live a productive lifestyle and do the things that they weren’t able to do before the development of their disease. Chronic disease and ailments do not have to affect your way of living.

Seattle Genetics wants to see you take your life in your own hands with advanced care that is proven to work.

https://www.crunchbase.com/person/clay-b-siegall#/entity

https://www.youtube.com/watch?v=Y477jsjn6yk